DBVT Stock: DBV Technologies S.A. Stock Price, Analysis & Insights

Get live DBVT stock price $16.03, comprehensive DBV Technologies S.A. stock analysis, charts, news, and expert forecast. Real-time DBVT stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

16.03

0.19%Today

DBVT • DBV Technologies S.A. • NASDAQ Global Select • Healthcare

Market Cap

383.47M

Volume

117.75K

52W High

26.18

52W Low

8.50

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase II...

Contact Information

Website: https://www.dbv-technologies.com
Address: 177-181 Avenue Pierre Brossolette
Country: FR

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -0.22) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for DBV Technologies S.A. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for DBV Technologies S.A.
⚠Investors should consider how DBV Technologies S.A. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

383.47M

P/E Ratio (TTM)

-3.56

Beta

-0.22

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare DBVT with peer companies:

Altimmune, Inc. (ALT)

Price: $2.66
Market cap: 234.76M

Amarin Corporation plc (AMRN)

Price: $14.89
Market cap: 307.97M

Annexon, Inc. (ANNX)

Price: $5.20
Market cap: 621.89M

Alto Neuroscience, Inc. (ANRO)

Price: $21.15
Market cap: 742.24M

Cellectis S.A. (CLLS)

Price: $2.99
Market cap: 300.25M

enGene Holdings Inc. (ENGN)

Price: $1.67
Market cap: 85.50M

Korro Bio, Inc. (KRRO)

Price: $10.94
Market cap: 108.89M

LB Pharmaceuticals Inc Common Stock (LBRX)

Price: $29.27
Market cap: 839.37M

Larimar Therapeutics, Inc. (LRMR)

Price: $3.50
Market cap: 299.52M

Lexeo Therapeutics, Inc. Common Stock (LXEO)

Price: $4.24
Market cap: 332.93M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.